Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to KYTX Full portfolio

Position in KYTX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$204,786
+$164,441 QoQ
Shares Held
22,984
+391.6% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 120 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 19% Shared 0% None 81%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. KYTX ranks #233 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in KYTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $204,786 22,984
2026-03-31 $40,345 4,675
2025-12-31 $40,175 4,274
2025-09-30 $40,050 6,675
2025-06-30 $85,514 27,855
2025-03-31 $76,238 39,502
2024-12-31 $8,102,473 2,166,437
2024-09-30 $11,674,147 2,387,352
2024-06-30 $15,459,427 2,061,257
2024-03-31 $20,976,510 844,465